secwatch.observer — SEC 8-K summary
======================================

Issuer:     Corvex, Inc. (MOVE)
CIK:        0001734750
Form:       8-K
Filed at:   2024-11-14T23:59:59+00:00
Accession:  0001213900-24-098462
Event type: earnings
Sentiment:  neutral
Materiality: 0.60
Item codes: 2.02, 9.01
LLM model:  deepseek-v4-flash:cloud@v2

Movano Health reports Q3 operating loss $7.4M, ships 339 Evie Rings, reverse split completed
--------------------------------------------------------------------------------

- Operating loss of $7.4M in Q3 2024, improved from $9.1M loss in Q3 2023.
- Cash and equivalents at Sept 30, 2024: $11.3M.
- 1-for-15 reverse stock split executed Oct 29; Nasdaq bid price compliance regained Nov 12.
- EvieMED 510(k) review in final stage; complete response submitted late Oct for medical features.
- Entered agreement phase for Q1 2025 pilot program with large healthcare company using EvieMED.

Source:
  EDGAR index:    https://www.sec.gov/Archives/edgar/data/1734750/000121390024098462/0001213900-24-098462-index.htm
  Primary doc:    https://www.sec.gov/Archives/edgar/data/1734750/000121390024098462/ea0220897-8k_movano.htm
  HTML page:      https://secwatch.observer/filing/0001213900-24-098462

License: Source filings: public domain (SEC EDGAR). Summaries (headline + bullets): CC-BY-4.0; attribute https://secwatch.observer